Patients inject the medications, typically in the stomach or thigh, once a week, with a needle similar to those used in injections for diabetes
Daily use is a preference, not a requirement, and it burns through a vial about three times faster
Conversely, although off-label use of GLP-1 RA for overweight and obesity cannot be excluded, such use was likely limited in the present study given existing prescription guidelines and regulatory vigilance
At the 2026 American Diabetes Association Scientific Sessions, investigators unveiled a wave of late-stage obesity trial results that could reshape clinical practice
Doctors may recommend a baseline eye exam for people with diabetes, especially before starting certain GLP-1 medicines
Identity and purity documentation is available by lot upon request